Form 8-K - Current report:
SEC Accession No. 0001641172-25-009564
Filing Date
2025-05-12
Accepted
2025-05-12 07:30:25
Documents
15
Period of Report
2025-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 40126
2 EX-99.1 ex99-1.htm EX-99.1 11995
3 GRAPHIC ex99-1_001.jpg GRAPHIC 24398
  Complete submission text file 0001641172-25-009564.txt   264134

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20250509.xsd EX-101.SCH 3045
5 XBRL LABEL FILE abeo-20250509_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE abeo-20250509_pre.xml EX-101.PRE 22379
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3679
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 25932581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)